2 Steps
Maximum: 1 CME cr.
Sign in to view your progression
Program overview
Educational goals
Target audience
Credit designation
Disclosures

Topic description:
This learning module summarizes the nomenclature, basic physiology, and principles in the clinical evaluation and management of female arousal disorders.

Video segments in the learning module:
- Video 1: Female Sexual Arousal Disorders: Prevalence, Physiology, Classification
- Video 2: Clinical Evaluation of Female Genital Arousal Disorder
- Video 3: Clinical Management of Arousal Disorders

Faculty Information
Lisa Larkin, MD
President, Lisa Larkin MD and Associates
Cincinnati, Ohio

Leah S. Millheiser, MD
Clinical Assistant Professor of Obstetrics and Gynecology
Stanford University School of Medicine
Palo Alto, California

Rachel Rubin, MD
IntimMedicine Specialists
Washington, District of Columbia

Best practice:
Discussion with patients with arousal disorders should include the various pathophysiologies and strategies for the management of central and genital arousal disorders.

Current practice:
Assessment of arousal is often limited to the physiologic phenomenon of lubrication only which leads to treatment options that only focus on this one aspect of arousal.

Resulting gaps:
Patients are rarely treated for arousal problems because their HCPs do not complete a full assessment.

Outcome indicated/Improvement in:
Patients have multiple versions of arousal dysfunction and each is managed logically and rationally.

Learning objectives:
(1) Understand different etiologies of arousal disorders.
(2) Adopt holistic approach in evaluating and managing arousal disorders.

Medical health care practitioners (MDs, DOs, PAs, NPs, etc.) in any field (Sexual Medicine, Obstetrics & Gynecology, Internal Medicine, Family Medicine, Urology, etc.) who would like to address sexual health in caring for their female patients.

ISSWSH Learner Notification

Module 4: Management of Arousal Disorders, From Anatomy Through Diagnosis to Treatment
Dr. L. Larkin, Dr. L. Millheiser, Dr. R. Rubin

February 1, 2019 – February 1, 2021
Online

Acknowledgment of Financial Commercial Support
Valeant Pharmaceuticals North America LLC

Acknowledgment of In-Kind Commercial Support (Only for ACCME, ANCC and ACPE)
No in-kind commercial support was received for this educational activity.

Satisfactory Completion
Learners must listen to each self-directed audio recording while following along with the visual slides/read the articles, pass the self-assessment questionnaire with a score of 80% or higher and complete an evaluation form to receive a certificate of completion. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.

Physicians

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and International Society for the Study of Women’s Sexual Health (ISSWSH). Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statement – Amedco LLC designates this internet activity enduring material for a maximum of 1 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Objectives - After attending this program you should be able to:

  1. Differentiate between central and genital arousal
  2. Differentiate between arousal disorder and vaginal dryness

The following disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco.

All of these relationships were treated as a conflict of interest and have been resolved. (C7 SCS 6.1-­‐6.2, 6.5)
All individuals in a position to control the content of CE are listed below.

First

Last

Commercial Interest

Lisa

Larkin

AMAG:Consultant, Proctor and Gamble:Consultant, TherapeuticsMD:Consultant, Amgen:Speakers Bureau

Leah

Millheiser

Aytu Women's Health, LLC:Consultant, Sprout Pharmaceuticals, Inc:Employee, hers.com:Consultant, Amag:Consultant, Willow, Inc:Consultant, Hupnos:Consultant

Rachel

Rubin

IPSEN:Research Grant Site Principal Investigator

Management of Arousal Disorders, from Anatomy through Diagnosis to Treatment
Self-assessment & Certificate

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies